Loading...

MaxCyte, Inc.

MXCTNASDAQ
Healthcare
Medical - Devices
$2.25
$-0.02(-0.88%)

MaxCyte, Inc. (MXCT) Company Profile & Overview

Explore MaxCyte, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

MaxCyte, Inc. (MXCT) Company Profile & Overview

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

SectorHealthcare
IndustryMedical - Devices
CEOMaher Masoud

Contact Information

301 944 1700
9713 Key West Avenue, Rockville, MD, 20850

Company Facts

114 Employees
IPO DateJul 30, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;